Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Wolters
L M
LM
Honkoop
P
P
Niesters
H G
HG
de Man
R A
RA
D015075:2-Aminopurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D004259:DNA-Directed DNA Polymerase / Q000235:genetics*; D000077595:Famciclovir; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000201:enzymology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D017354:Point Mutation; D011355:Prodrugs / Q000627:therapeutic use
D000998:Antiviral Agents; D004279:DNA, Viral; D011355:Prodrugs; D019259:Lamivudine; D015075:2-Aminopurine; D000410:Alanine Transaminase; D004259:DNA-Directed DNA Polymerase; D000077595:Famciclovir